MyAverix Finance
SHG · Healthcare
Xiamen Amoytop Biotech Co Ltd (688278)
Biotechnology
Xiamen Amoytop Biotech Co Ltd (688278) is listed on SHG in the Healthcare sector. Industry: Biotechnology. As of 2026-03-29, reported market cap is $27.72B, P/E ratio is 26.95, net margin is 28.1%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 688278
Xiamen Amoytop Biotech Co Ltd (688278) — FAQ
What is Xiamen Amoytop Biotech Co Ltd's market cap?
Xiamen Amoytop Biotech Co Ltd (688278) has a reported market cap of $27.72B (data as of 2026-03-29).
What is 688278's P/E ratio?
The price-to-earnings (P/E) ratio for Xiamen Amoytop Biotech Co Ltd (688278) is 26.95 (data as of 2026-03-29).
Does Xiamen Amoytop Biotech Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Xiamen Amoytop Biotech Co Ltd (688278). Check the MyAverix Finance app for the latest dividend data.
What sector is Xiamen Amoytop Biotech Co Ltd in?
Xiamen Amoytop Biotech Co Ltd (688278) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 688278 listed on?
688278 is listed on SHG.
What is Xiamen Amoytop Biotech Co Ltd's net margin?
Xiamen Amoytop Biotech Co Ltd (688278) reports a net margin of 28.1% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.